Insider Stock Trading History of Mangano Ross J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Mangano Ross J since year 2005. The trader's CIK number is 1013724. At the time of this reporting, Mangano Ross J is the of Biosante Pharmaceuticals Inc . (stock ticker symbol bpa). See this page for all insider trading activities at Biosante Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Mangano Ross J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-09-15 ANIP Biosante Pharmaceuticals Inc Buy 3,000 27.49 82,476
2014-05-07 ANIP Biosante Pharmaceuticals Inc Buy 2,000 30.38 60,760
2013-11-07 ANIP Biosante Pharmaceuticals Inc Buy 9,000 11.27 101,430
2013-08-20 ANIP Biosante Pharmaceuticals Inc Buy 10,000 7.47 74,660
2011-08-12 BPAX Biosante Pharmaceuticals Inc Buy 25,000 2.40 60,000
2011-08-05 BPAX Biosante Pharmaceuticals Inc Buy 80,000 2.21 176,800
2010-12-07 BPAX Biosante Pharmaceuticals Inc Buy 20,000 1.47 29,400
2008-12-29 BPAX Biosante Pharmaceuticals Inc Buy 25,000 1.19 29,675
2008-05-12 BPAX Biosante Pharmaceuticals Inc Buy 15,000 3.59 53,820
2008-01-04 BPAX Biosante Pharmaceuticals Inc Buy 50,000 3.73 186,500
2007-12-20 BPAX Biosante Pharmaceuticals Inc Buy 25,000 3.98 99,500
2007-12-19 BPAX Biosante Pharmaceuticals Inc Buy 50,000 3.69 184,700
2006-12-26 BPA Biosante Pharmaceuticals Inc Buy 15,000 2.69 40,365
2006-11-16 BPA Biosante Pharmaceuticals Inc Buy 100,000 1.50 150,000
2006-07-19 BPA Biosante Pharmaceuticals Inc Buy 14,800 1.90 28,120
2006-07-14 BPA Biosante Pharmaceuticals Inc Buy 13,800 1.92 26,496

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mangano Ross J ( of Biosante Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.